(RS)-CPPCAS# 100828-16-8 |
- INCB3344
Catalog No.:BCC1648
CAS No.:1262238-11-8
- INCB8761(PF-4136309)
Catalog No.:BCC1649
CAS No.:1341224-83-6
- MK-0812
Catalog No.:BCC1755
CAS No.:624733-88-6
- INCB 3284 dimesylate
Catalog No.:BCC1646
CAS No.:887401-93-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 100828-16-8 | SDF | Download SDF |
PubChem ID | 1228 | Appearance | Powder |
Formula | C8H17N2O5P | M.Wt | 252.21 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in water | ||
Chemical Name | 4-(3-phosphonopropyl)piperazine-2-carboxylic acid | ||
SMILES | C1CN(CC(N1)C(=O)O)CCCP(=O)(O)O | ||
Standard InChIKey | CUVGUPIVTLGRGI-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C8H17N2O5P/c11-8(12)7-6-10(4-2-9-7)3-1-5-16(13,14)15/h7,9H,1-6H2,(H,11,12)(H2,13,14,15) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Potent NMDA antagonist. Separate isomer (R)-CPP also available. |
(RS)-CPP Dilution Calculator
(RS)-CPP Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.9649 mL | 19.8247 mL | 39.6495 mL | 79.299 mL | 99.1237 mL |
5 mM | 0.793 mL | 3.9649 mL | 7.9299 mL | 15.8598 mL | 19.8247 mL |
10 mM | 0.3965 mL | 1.9825 mL | 3.9649 mL | 7.9299 mL | 9.9124 mL |
50 mM | 0.0793 mL | 0.3965 mL | 0.793 mL | 1.586 mL | 1.9825 mL |
100 mM | 0.0396 mL | 0.1982 mL | 0.3965 mL | 0.793 mL | 0.9912 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 4,4'-Bis(α,α-dimethylbenzyl)diphenylamine
Catalog No.:BCC8661
CAS No.:10081-67-1
- Chlorahololide C
Catalog No.:BCN7256
CAS No.:1007859-25-7
- (R)-5-Hydroxy-1,7-diphenyl-3-heptanone
Catalog No.:BCN3591
CAS No.:100761-20-4
- Ganoderic acid M
Catalog No.:BCN2871
CAS No.:100761-17-9
- 1-O-Deacetylkhayanolide E
Catalog No.:BCN5823
CAS No.:1007387-95-2
- CH5132799
Catalog No.:BCC4991
CAS No.:1007207-67-1
- 3-(Hydroxymethyl)cyclopentanol
Catalog No.:BCN5822
CAS No.:1007125-14-5
- Deacetyl ganoderic acid F
Catalog No.:BCN2870
CAS No.:100665-44-9
- Ganoderenic acid D
Catalog No.:BCN2445
CAS No.:100665-43-8
- Ganoderenic acid C
Catalog No.:BCN3210
CAS No.:100665-42-7
- Ganoderenic acid B
Catalog No.:BCN7966
CAS No.:100665-41-6
- Ganoderenic acid A
Catalog No.:BCN3208
CAS No.:100665-40-5
- Piceatannol
Catalog No.:BCN5824
CAS No.:10083-24-6
- Panamycin 607
Catalog No.:BCN1813
CAS No.:100905-89-3
- AZD8055
Catalog No.:BCC3629
CAS No.:1009298-09-2
- AZD2014
Catalog No.:BCC3732
CAS No.:1009298-59-2
- Caulophyllumine A
Catalog No.:BCN7928
CAS No.:1009318-60-8
- Stachyose
Catalog No.:BCN2566
CAS No.:10094-58-3
- 2,2-Bis(hydroxymethyl)butyric acid
Catalog No.:BCC8495
CAS No.:10097-02-6
- Rotundine
Catalog No.:BCN5983
CAS No.:10097-84-4
- Ebrotidine
Catalog No.:BCC1542
CAS No.:100981-43-9
- Thiamet G
Catalog No.:BCC4864
CAS No.:1009816-48-1
- NSC 687852 (b-AP15)
Catalog No.:BCC2389
CAS No.:1009817-63-3
- CX-4945 (Silmitasertib)
Catalog No.:BCC3693
CAS No.:1009820-21-6
CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity.[Pubmed:2876749]
Brain Res. 1986 Sep 10;382(1):169-73.
Properties of a new potent antagonist acting selectively at N-methyl-D-aspartate (NMDA) type excitatory amino acid receptors are described. This compound, 3-((+/-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) is more potent than all previously reported NMDA antagonists in depressing mammalian spinal neuronal responses (cat and immature rat), in its affinity for [3H]D-AP5 (a radiolabelled NMDA antagonist) binding sites on rat brain membranes, and as an anticonvulsant in mice.